Hosted on MSN50m
Actinogen receives $9M R&D tax rebate to fund Alzheimer's trialActinogen Medical Ltd (ASX:ACW) has received a $9 million R&D (research and development) tax incentive rebate for the 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback